GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human PI3K-gamma in complex with quinoline- containing inhibitor 5G

Analyse Crystal structure of human PI3K-gamma in complex with quinoline- containing… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5KAE
Type
protein
Length
840 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.153, 2.7.11.1
UniProt
P48736
Ligands
6RF, SO4
Pockets
12 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.153, 2.7.11.1)protein84045% helix, 18% strandP48736

Ligands and binding sites

  • 6RF · 4-azanyl-6-[[(1~{S})-1-(6-fluoranyl-3-phenyl-4-piperazin-1-ylcarbonyl-quinolin-2-yl) ethyl]amino]pyrimidine-5-carbonitrile · ligand · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111130.820.8378SO4
24830.700.80486RF
33110.700.8334empty
41080.620.8723empty
51820.570.8128empty

Compared structures

  • 5KAE · Crystal structure of human PI3K-gamma in complex with quinoline-containing inhibitor 5g · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.